chr11-5884385-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005165.2(OR52E4):āc.93C>Gā(p.Phe31Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000452 in 1,613,288 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001005165.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR52E4 | NM_001005165.2 | c.93C>G | p.Phe31Leu | missense_variant | 2/2 | ENST00000641726.1 | |
LOC112268071 | XR_002957231.2 | n.365-2956G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR52E4 | ENST00000641726.1 | c.93C>G | p.Phe31Leu | missense_variant | 2/2 | NM_001005165.2 | P1 | ||
TRIM5 | ENST00000412903.1 | c.-62+53016G>C | intron_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152032Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251074Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135682
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1461138Hom.: 0 Cov.: 32 AF XY: 0.0000248 AC XY: 18AN XY: 726900
GnomAD4 genome AF: 0.000243 AC: 37AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.93C>G (p.F31L) alteration is located in exon 1 (coding exon 1) of the OR52E4 gene. This alteration results from a C to G substitution at nucleotide position 93, causing the phenylalanine (F) at amino acid position 31 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at